Literature DB >> 25064449

Differential effect of cataract-associated mutations in MAF on transactivation of MAF target genes.

Vanita Vanita1, Gao Guo, Daljit Singh, Claus-Eric Ott, Peter N Robinson.   

Abstract

Three mutations in the highly conserved DNA-binding region of c-MAF (R288P, K297R, and R299S) are associated with phenotypically distinct forms of autosomal dominant congenital cataract. However, the molecular mechanisms underlying this phenotypic diversity remain unclear. In this work, we have investigated the hypothesis that differential transactivation of MAF target genes could be one factor determining the phenotypic differences. Promoter constructs were generated for four human crystallin genes with conserved half-site MAF responsive elements (MARE). MAF expression constructs were constructed with the wildtype MAF sequence and with each of the three known mutations, i.e., R288P (associated with pulverulent cataract), K297R (associated with cerulean cataract), and R299S (associated with the most severe phenotype, congenital cataract, and microcornea syndrome). Transactivation was measured using luciferase reporter assays following cotransfection in HEK cells. Responsiveness to wildtype c-MAF was established for each of the four crystallin promoter constructs. The same constructs were then investigated using c-MAF mutants corresponding to each of the three mutations. A differential response was noted for each of the tested crystallin genes. The mutation R288P significantly reduced the expression of the CRYGA and CRYBA1 constructs but had no significant effect on the other two constructs. K297R did not lead to a significant reduction in expression of any of the four constructs, although there was a tendency toward reduced expression especially for the CRYGA construct. R299S, which is associated with the most severe phenotype, congenital cataract, and microcornea syndrome, was associated with the most severe overall effect on the transactivation of the four crystallin expression constructs. Our findings suggest that differential effects of mutations on the transactivation potential of c-MAF could be a molecular correlate of the striking genotype-phenotype correlations seen in cataract forms caused by mutations in the MAF gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25064449     DOI: 10.1007/s11010-014-2150-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  A heterozygous c-Maf transactivation domain mutation causes congenital cataract and enhances target gene activation.

Authors:  R Perveen; J Favor; R V Jamieson; D W Ray; G C M Black
Journal:  Hum Mol Genet       Date:  2007-03-20       Impact factor: 6.150

2.  Clinical and genetic heterogeneity in autosomal dominant cataract.

Authors:  A Ionides; P Francis; V Berry; D Mackay; S Bhattacharya; A Shiels; A Moore
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 3.  Epigenetic regulatory mechanisms in vertebrate eye development and disease.

Authors:  A Cvekl; K P Mitton
Journal:  Heredity (Edinb)       Date:  2010-02-24       Impact factor: 3.821

4.  A unique form of autosomal dominant cataract explained by gene conversion between beta-crystallin B2 and its pseudogene.

Authors:  V Sarhadi; A Reis; M Jung; D Singh; K Sperling; J R Singh; J Bürger
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

5.  Novel MAF mutation in a family with congenital cataract-microcornea syndrome.

Authors:  Lars Hansen; Hans Eiberg; Thomas Rosenberg
Journal:  Mol Vis       Date:  2007-10-18       Impact factor: 2.367

6.  A progressive early onset cataract gene maps to human chromosome 17q24.

Authors:  M M Armitage; J D Kivlin; R E Ferrell
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

7.  Comprehensive mutational screening in a cohort of Danish families with hereditary congenital cataract.

Authors:  Lars Hansen; Annemette Mikkelsen; Peter Nürnberg; Gudrun Nürnberg; Iram Anjum; Hans Eiberg; Thomas Rosenberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

8.  Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Authors:  M Chesi; P L Bergsagel; O O Shonukan; M L Martelli; L A Brents; T Chen; E Schröck; T Ried; W M Kuehl
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

9.  Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma.

Authors:  Robyn V Jamieson; Rahat Perveen; Bronwyn Kerr; Martin Carette; Jill Yardley; Elise Heon; M Gabriela Wirth; Veronica van Heyningen; Di Donnai; Francis Munier; Graeme C M Black
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

10.  Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.

Authors:  Jeong Eun Park; Alexander I Son; Rui Hua; Lianqing Wang; Xue Zhang; Renping Zhou
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

View more
  3 in total

Review 1.  Molecular Genetics of Cataract.

Authors:  Alan Shiels; J Fielding Hejtmancik
Journal:  Prog Mol Biol Transl Sci       Date:  2015-06-12       Impact factor: 3.622

2.  Segregation of a novel p.(Ser270Tyr) MAF mutation and p.(Tyr56∗) CRYGD variant in a family with dominantly inherited congenital cataracts.

Authors:  Lubica Dudakova; Viktor Stranecky; Olga Ulmanova; Eva Hlavova; Marie Trková; Andrea L Vincent; Petra Liskova
Journal:  Mol Biol Rep       Date:  2017-08-28       Impact factor: 2.316

3.  Aberrant TGF-β1 signaling activation by MAF underlies pathological lens growth in high myopia.

Authors:  Xiangjia Zhu; Yu Du; Dan Li; Jie Xu; Qingfeng Wu; Wenwen He; Keke Zhang; Jie Zhu; Linying Guo; Ming Qi; Ailin Liu; Jiao Qi; Guangyu Wang; Jiaqi Meng; Zhenglin Yang; Kang Zhang; Yi Lu
Journal:  Nat Commun       Date:  2021-04-08       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.